Cargando…
Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer
INTRODUCTION: Small cell lung cancer (SCLC) is a rapidly growing malignancy with early distant metastases. Up to 70% will develop brain metastases, and the poor prognosis of these patients has not changed considerably. The potential of checkpoint inhibitors (CPI) in treating recurrent (r/r) SCLC and...
Autores principales: | Althoff, Friederike C., Schäfer, Lisa V., Acker, Fabian, Aguinarte, Lukas, Heinzen, Sophie, Rost, Maximilian, Atmaca, Akin, Rosery, Vivian, Alt, Jürgen, Waller, Cornelius F., Reinmuth, Niels, Rohde, Gernot, Saalfeld, Felix C., Becker von Rose, Aaron, Möller, Miriam, Frost, Nikolaj, Sebastian, Martin, Stratmann, Jan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556470/ https://www.ncbi.nlm.nih.gov/pubmed/37810988 http://dx.doi.org/10.3389/fonc.2023.1273478 |
Ejemplares similares
-
Clinical predictors of survival in patients with relapsed/refractory
small-cell lung cancer treated with checkpoint inhibitors: a German multicentric
real-world analysis
por: Stratmann, Jan A., et al.
Publicado: (2022) -
Spindle checkpoint–independent inhibition of mitotic chromosome segregation by Drosophila Mps1
por: Althoff, Friederike, et al.
Publicado: (2012) -
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor
por: Schröter, Nils, et al.
Publicado: (2020) -
Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy
por: Mülling, Nils, et al.
Publicado: (2021) -
A New Serum Macrophage Checkpoint Biomarker for Innate Immunotherapy: Soluble Signal-Regulatory Protein Alpha (sSIRPα)
por: Vladimirova, Yoanna V., et al.
Publicado: (2022)